Effects of Chung-Pae Inhalation Therapy on a Mouse Model of Chronic Obstructive Pulmonary Disease. (11th October 2015)

• Record Type: Journal Article
• Authors: Hwang, Joon-Ho; Lee, Beom-Joon; Jung, Hee Jae; Kim, Kwan-Il; Choi, Jun-Yong; Joo, Myungsoo; Jung, Sung-Ki
• Other Names: Yasukawa Ken Academic Editor.
• Is Part Of: Evidence-based complementary and alternative medicine. Volume 2015(2015)
• Publication Date: 2015-10-11
• Subjects: Alternative medicine -- Periodicals; 615.505
• DOI: 10.1155/2015/461295
• Languages: English
• ISSNs: 1741-427X

Abstract

Abstract : Chung-pae (CP) inhalation therapy is a method frequently used in Korea to treat lung disease, especially chronic obstructive pulmonary disease (COPD). This study investigated the effects of CP inhalation on a COPD animal model. C57BL/6 mice received porcine pancreatic elastase (PPE) and lipopolysaccharide (LPS) alternately three times for 3 weeks to induce COPD. Then, CP (5 or 20 mg/kg) was administered every 2 h after the final LPS administration. The effect of CP was evaluated by bronchoalveolar lavage (BAL) fluid analysis, histological analysis of lung tissue, and reverse transcription polymerase chain reaction analysis of mRNA of interleukin- (IL-) 1 β, tumor necrosis factor- (TNF-) α, IL-6, and tumor growth factor- (TGF-) β . Intratracheal CP administration reduced the number of leukocytes and neutrophils in BAL fluid, inhibited the histological appearance of lung damage, and decreased the mRNA levels of the proinflammatory cytokines IL-1 β, TNF- α, IL-6, and TGF- β . Intratracheal CP administration effectively decreased the chronic inflammation and pathological changes in a PPE- and LPS-induced COPD mouse model. Therefore, we suggest that CP is a promising strategy for COPD.